Week 231 Review - Not a lot happened

I'm on a post-holiday catch-up so the next 2 updates will be brief and just act as a record of where we were at the end of each week. Not a bad week, with portfolio value dropping by £952 and the deficit between cost and value widening to £25,810. Total value is £81,409.

The only big mover was IKA:Ilika, which rose 13% on the back of a 14% rise last week wo earn Share of the Week again.This is now only 12% down.

Here's the ISA and share accounts snapshot

			Weekly Change
Cash	£11.99		-£3.75
Portfolio cost	£57,768.95		+£0
Portfolio sell value (bid price-commission)	£42,329.65	(-27.5%)	-£452.46
Potential profits	£0		+£0
Yr 5 Dividends	£0.63		+£0
Yr 5 Profit from sales	£-167.28		+£0
Yr 5 Average monthly cash profit	-£34.93	(-0.7%)	+£0.85
Total Dividends	£1,342.93		+£0
Total Profit from sales	£20,224.13		+£0
Average monthly cash profit	£400.63	(8.3%)	-£1.81
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	13.0%		+0%
Compound performance	57%		+0%

The biggest drop was caused by a 1p fall in OPTI:Optibiotix.

Here's the SIPP after week 215

			Weekly Change
Cash	£74.75		-£16.22
Portfolio cost	£46,995.31		+£0
Portfolio sell value (bid price - commission)	£38,116.17	(-18.9%)	-£498.64
Potential profits	£752.97		+£60.00
Yr 5 Dividends	£0		+£0
Yr 5 Interest	£0.02		+£0.01
Yr 5 Profit from sales	£0		+£0
Yr 5 Average monthly cash profit	-£17.69	(-0.4%)	-£8.77
Total Dividends	£1,899.24		+£0
Total Interest	£0.18		+£0.01
Total Profit from sales	£12,549.10		+£0
Average monthly cash profit	£283.34	(7.2%)	-£1.33
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	11.3%		-0.1%
Compound performance	47%		+0%

Similar story to above, but an extra £60 on CAML:Central Asia Metals potential profits and cash and year 5 monthly average profits down due to monthly charges.

Here's the trading portfolio after Week 181

		Weekly Change
Cash	£48.24		+£0
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,281.23	(-44.8%)	-£1.57
Potential profits	£0		+£0
Year 4 Dividends	£13.20		+£0
Year 4 Profit	£0		+£0
Yr 4 Average monthly cash profit	£2.29	(1.2%)	-£0.09
Dividends	£47.92		+£0
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£0.39	(-0.2%)	+£0
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	-0.2%		+0%
Compound performance	-1%		+0%

Hardly any change here